Varian forms global clinical council for RapidArc
Varian Medical Systems has formed a council of cancer centers in North America and Europe to further the development of clinical protocols using its RapidArc radiotherapy technology for fast and precise cancer treatments.

RapidArc makes it possible to deliver advanced image-guided, intensity-modulated radiation therapy (IMRT) two to eight times faster than is possible with conventional IMRT or helical tomotherapy, according to the Palo Alto, Calif.-based company.

The RapidArc council members include researchers and scientists from the VU University Medical Center in Amsterdam, Netherlands; Rigshospitalet in Copenhagen, Denmark; CRLC Val d'Aurelle in Montpellier, France; University Hospital in Zurich, Switzerland; BC Cancer Agency in Vancouver, Canada; University of Maryland Marlene and Stewart Greenebaum Cancer Center in Baltimore; and University of Alabama at Birmingham, Ala.

Varian said that council members have been working with early versions of the RapidArc system to potentially expand clinical applications for the new treatment method and intend to develop additional clinical presentations on the new technology for submission to scientific meetings, journals and symposia.

In addition, the council members will collaborate with Varian engineers and developers in Switzerland, Finland and the United States on future enhancements to the technology.